Lv2
130 积分 2022-09-05 加入
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
21天前
已完结
Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer
27天前
已完结
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
3个月前
已完结
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
3个月前
已完结
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
3个月前
已完结
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study
5个月前
已完结
Global Stage Distribution of Breast Cancer at Diagnosis
6个月前
已完结
Global Stage Distribution of Breast Cancer at Diagnosis
6个月前
已完结
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
7个月前
已完结
Breast cancer
7个月前
已完结
皖公网安备34019202002308
